Cryptococcus neoformans infection in mice previously infected with LP- BM5 MuLV, the agent of murine AIDS (MAIDS)

Clinical and Experimental Immunology

Volumn 110, Issue 2, 1997, Pages 196-202

  Lacroix, C ^a,b   Chau, F ^a   Carbon, C ^a   Sinet, M ^a   Derouin, F ^b  

^a BICHAT HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Co infection; Cryptococcus neoformans; Interferon gamma; MAIDS

Indexed keywords

GAMMA INTERFERON;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; INFECTION; MOUSE; MYCOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0030731334     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.tb08317.x     Document Type: Article

References (37)

1. Powderly WG. Cryptococcal meningitis and AIDS. Clin Inf Dis 1993; 17:837-42.
2. Salkowski CA, Balish E. Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient Beige athymic mice. Infect Immun 1990; 58:3300-6.
3. + T cells. J Exp Med 1991; 173:755-8.
4. Huffnagle GB, Yates JL, Lipscomb M. T-cell mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect Immun 1991; 59:1423-33.
5. Clemons KV, Azzi R, Stevens DA. Experimental systemic cryptococcosis in SCID mice. J Med Vet Mycol 1996; 34:331-5.
6. Murphy JW. Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response. Infect Immun 1993; 61:4750-9.
7. Aguirre K, Havell EA, Gibson GW et al. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system. Infect Immun 1995; 63:1725-31.
8. Kawakami K, Tohyama M, Terruya K et al. Contribution of interteron-γ in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol Med Mic 1996; 13:123-30.
9. Kawakami K, Tohyama M, Xie Q et al. IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin Exp Immunol 1996; 104:208-14.
10. Morse HC, Chattopadhyay SK, Makino M et al. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 1992; 6:607-21.
11. Mosier DE, Yetter RA, Morse HC. Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57B1/6 mice. J Exp Med 1985; 161:766-84.
12. + T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J Exp Med 1988; 168:623-35.
13. Morse HC, Yetter RA, Via CS et al. Functional and phenotypic alterations in T-cell subsets during the course of MAIDS, a murine retrovirus-induced syndrome. J Immunol 1989; 143:844-50.
14. Muralidhar G, Koch S, Haas M et al. CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy. J Exp Med 1992; 175:1589-99.
15. + subset regulation in viral infection: preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol 1992; 148:182-8.
16. Darban H, Enriquez J, Sterling CR et al. Cryptosporidiosis facilitated by murine retroviral infection with LP-BM5. J Infect Dis 1991; 164:741-5.
17. Cole GT, Saha K, Seshan KR et al. Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis. Infect Immun 1992; 60:4168-78.
18. Gazzinelli RT, Hartley JW, Fredrickson TN et al. Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses. Infect Immun 1992; 60:4394-401.
19. Lacroix C, Levacher M, Chau F et al. Interactions between murine AIDS (MAIDS) and toxoplasmosis in co-infected mice. Clin Exp Immunol 1994; 98:190-5.
20. Barral-Netto M, Santana da Silva J, Barral A et al. Up-regulation of T helper 2 and down-regulation of T helper 1 cytokines during murine retrovirus-induced immunodeficiency syndrome enhances susceptibility of a resistant mouse strain to Leishmania amazonensis. Am J Pathol 1995; 146:635-42.
21. Bassin RH, Tuttle N, Fischinger PJ. Rapid cell culture assay technique for murine leukaemia viruses. Nature 1971; 229:564-6.
22. +) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J Immunol 1990; 144:1472-7.
23. Levitz SM, Dupont MP, Smail EH. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infect Immun 1994; 62:194-202.
24. Kawakami K, Qifeng X, Tohyama M et al. Contribution of tumor necrosis factor-alpha (TNF-α) in host defence mechanism against Cryptococcus neoformans. Clin Exp Immunol 1996: 106:468-74.
25. Mody CH, Paine R, Jackson C et al. CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans. J Immunol 1994; 152:3970-9.
26. + T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J Exp Med 1992; 175:1685-95.
27. Cheung SC, Chattopadhyay S, Morse HC et al. Expression of detective virus and cytokine genes in murine AIDS. J Virol 1991; 65:823-8.
28. Wang Y, Huang DS, Giger PT et al. The kinetics of unbalanced cytokine production by T cells and macrophages during MAIDS? Adv Biosci 1993; 86:335-40.
29. Cunnigham RK, Thacore HR, Zhou P et al. Murine AIDS: a model for the human disease or a distinct entity? Immunol Res 1994; 13:21-8.
30. Torbett BE, Mosier DE. Does preferential Th subset activation contribute to the murine acquired immunodeficiency disease (MAIDS)? Res Immunol 1994; 145:696-701.
31. Grassi F, Perronne C, Levacher M et al. Mycobacterium avium complex infection in mice: lack of exacerbation after LP-BM5 murine leukemia virus infection. Infect Immun 1996; 64:1203-7.
32. Doherty TM, Morse HC, Coffman RL. Modulation of specific T cell responses by concurrent infection with Leishmania major and LP-BM5 murine leukemia viruses. Int Immunol 1995; 7:131-8.
33. Hartley JW, Fredrickson TN, Yetter RA et al. Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J Virol 1989; 63:1223-31.
34. Uehara S, Hitoshi Y, Numata F et al. An IFN-γ-dependent pathway plays a critical role in the pathogenesis of murine immunodeficiency syndrome induced by LP-BM5 murine leukemia virus. Int Immunol 1994; 6:1937-47.
35. Morse HC, Giese N, Morawetz R et al. Cells and cytokines in the pathogenesis of MAIDS, a retrovirus-induced immunodeficiency syndrome of mice. Springers Semin Immunopathol 1995; 17:231-245.
36. Pettoello-Mantovani M, Casadevall A, Kollmann TR et al. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet 1992; 339:21-3.
37. Orendi JM, Nottet H, Visser MR et al. Enhancement of HIV-1 replication in peripheral blood mononuclear cells by Cryptococcus neoformans is monocyte-dependent but tumor necrosis factor-independent. AIDS 1994; 8:423-9.